{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T14:36:08Z","timestamp":1776436568135,"version":"3.51.2"},"reference-count":20,"publisher":"Korean Cancer Association","issue":"2","license":[{"start":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T00:00:00Z","timestamp":1700611200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":["e-crt.org"],"crossmark-restriction":true},"short-container-title":["Cancer Res Treat"],"published-print":{"date-parts":[[2024,4,15]]},"abstract":"<jats:p>Purpose Perspectives of radiation oncologists on oligometastatic disease was investigated using multi-layered survey.Materials and Methods Online survey on the oligometastatic disease was distributed to the board-certified regular members of the Korean Society for Radiation Oncology. The questionnaire consisted of four domains: five questions on demographics; five on the definition of oligometastatic disease; four on the role of local therapy; and three on the oligometastatic disease classification, respectively.Results A total of 135 radiation oncologists participated in the survey. The median length of practice after board certification was 22.5 years (range, 1 to 44 years), and the vast majority (94.1%) answered affirmatively to the clinical experience in oligometastatic disease management. Nearly two-thirds of the respondents considered the number of involved organs as an independent factor in defining oligometastasis. Most frequently perceived upper limit on the numerical definition of oligometastasis was 5 (64.2%), followed by 3 (26.0%), respectively. Peritoneal and brain metastasis were nominated as the sites to be excluded from oligometastastic disease by 56.3% and 12.6% of the participants, respectively. Vast majority (82.1%) agreed on the role of local treatment in the management of oligometastatic disease. Majority (72%) of the participants acknowledged the European Society for Radiotherapy and Oncology (ESTRO)\u2013European Organisation for Research and Treatment of Cancer (EORTC) classification of oligometastatic disease, however, only 43.3% answered that they applied this classification in their clinical practice. Underlying reasons against the clinical use were \u2018too complicated\u2019 (66.0%), followed by \u2018insufficient supporting evidence\u2019 (30.0%), respectively.Conclusion While most radiation oncologists supported the role of local therapy in oligometastatic disease, there were several inconsistencies in defining and categorizing oligometastatic disease. Continued education and training on oligometastatic disease would be also required to build consensus among participating caregivers.<\/jats:p>","DOI":"10.4143\/crt.2023.876","type":"journal-article","created":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T00:49:45Z","timestamp":1700614185000},"page":"414-421","update-policy":"https:\/\/doi.org\/10.4143\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Radiation Oncologists\u2019 Perspectives on Oligometastatic Disease: A Korean Survey Study"],"prefix":"10.4143","volume":"56","author":[{"given":"Chai Hong","family":"Rim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won Kyung","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Hoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Seok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang-Gun","family":"Suh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ah Ram","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eui Kyu","family":"Chie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong Chan","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the Oligometastasis Working Group, Korean Cancer Association","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2954","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-19-0458"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gde.2010.10.011"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1200\/jco.1995.13.1.8"},{"key":"ref4","first-page":"1","volume-title":"Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of long-term survivors","author":"Hughes","year":"1988"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0142(19960401)77:7<1254::aid-cncr5>3.0.co;2-i"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-5223(97)70397-0"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2011.44"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(19)30718-1"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2022.1326"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2022.329"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2020.04.003"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1200\/jco.20.00818"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1200\/jco.19.00201"},{"key":"ref14","first-page":"1325","volume-title":"Consolidative use of radiotherapy to block (CURB) oligoprogression: interim analysis of the first randomized study of stereotactic body radiotherapy in patients with oligoprogressive mtastatic cancers of the lung and breast","author":"Tsai","year":"2021"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2014.96"},{"key":"ref16","first-page":"247","volume-title":"Stereotactic body radiotherapy for oligometastasis: opportunities for biology to guide clinical management","author":"Correa","year":"2016"},{"key":"ref17","first-page":"446","volume-title":"Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence: a prospective, randomized, multicenter phase II trial","author":"Ost","year":"2018"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.3501"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.0147"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2022.06.067"}],"container-title":["Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/e-crt.org\/upload\/pdf\/crt-2023-876.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/e-crt.org\/journal\/view.php?doi=10.4143\/crt.2023.876","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/e-crt.org\/upload\/pdf\/crt-2023-876.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T04:45:11Z","timestamp":1713242711000},"score":1,"resource":{"primary":{"URL":"http:\/\/e-crt.org\/journal\/view.php?doi=10.4143\/crt.2023.876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,15]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"URL":"https:\/\/doi.org\/10.4143\/crt.2023.876","relation":{},"ISSN":["1598-2998","2005-9256"],"issn-type":[{"value":"1598-2998","type":"print"},{"value":"2005-9256","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,15]]},"assertion":[{"value":"2023-07-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-20","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-22","order":2,"name":"published","label":"Published online","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-15","order":3,"name":"published","label":"Print publication","group":{"name":"publication_history","label":"Publication History"}}]}}